ArticleJournal of medical cases2022

Survival Benefit of Pembrolizumab for Patients With Pancreatic Adenocarcinoma: A Case Series.

Li Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.